Mamia Zodelava
About
In The Last Decade
Mamia Zodelava
12 papers receiving 379 citations
Peers
Comparison fields: 5 of 33
- Hematology 329
- Molecular Biology 171
- Genetics 131
- Public Health, Environmental and Occupational Health 56
- Oncology 38
Countries citing papers authored by Mamia Zodelava
This map shows the geographic impact of Mamia Zodelava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamia Zodelava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamia Zodelava more than expected).
Fields of papers citing papers by Mamia Zodelava
This network shows the impact of papers produced by Mamia Zodelava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamia Zodelava. The network helps show where Mamia Zodelava may publish in the future.
Co-authorship network of co-authors of Mamia Zodelava
This figure shows the co-authorship network connecting the top 25 collaborators of Mamia Zodelava. A scholar is included among the top collaborators of Mamia Zodelava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mamia Zodelava. Mamia Zodelava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | 12 | |
| 6 | 278 | |
| 7 | 4 | |
| 8 | 54 | |
| 9 | 11 | |
| 10 | 6 | |
| 11 | Prognostic significance of apoptosis-related CD95 antigen expression in patients with non-Hodgkin's lymphoma. | 3 |
| 12 | Early cardiotoxicity induced by treatment of hematologic malignancies and the risk-factors of its manifestation. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.